Close Menu

senior notes offering

As of May 6, there was $350 million in aggregate principal amount of the notes outstanding.

The firm used $314.3 million of the net proceeds from the offering to purchase 4,890,500 shares of its common stock.

Waters privately placed the notes with institutional investors.

Net proceeds from the offering will be used to buy back common stock, fund conversion on currently outstanding convertible notes, and general corporate purposes.

The firm will redeem all of its outstanding 3.25 percent convertible senior subordinated notes due 2024.

The firm sold $300 million aggregate principal amount of 2.05 percent senior notes due 2014; $900 million aggregate principal amount of 3.2 percent senior notes due 2016; and $1 billion aggregate principal amount of 4.5 percent senior notes due 2021.

The firm has yet to provide an estimated amount of proceeds from the notes offerings, which will help pay for its $2.1 billion acquisition of Dionex.

The proceeds would be used to redeem other outstanding notes.

The firm has offered $300 million in senior notes with a 10-year maturity.

The first series of $250 million in 2.5 percent notes will mature in July 2013. The second series of $500 million in 5 percent notes will mature in July 2020.


The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.